01 September 2005
Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.
Shih-Jen TsaiMed Sci Monit 2005; 11(9): HY39-45 :: ID: 428439
Abstract
The "glutamate hypothesis" of schizophrenia has emerged from the findingthat phencyclidine (PCP) induces psychotic-like behaviors in rodents, possibly by blocking the N-methyl-D-aspartate(NMDA) subtype of glutamate receptor, thereby causing increased glutamate release. N-acetyl aspartylglutamate(NAAG), an endogenous peptide abundant in mammalian nervous systems, is localized in certain brain cells,including cortical and hippocampal pyramidal neurons. NAAG is synthesized from N-acetylaspartate (NAA)and glutamate, and NAA availability may limit the rate of NAAG synthesis. Although NAAG is known to havesome neurotransmitter-like functions, NAA does not. NAAG is a highly selective agonist of the type 3metabotropic glutamate receptor (mGluR3, a presynaptic autoreceptor) and can inhibit glutamate release.In addition, at low levels, NAAG is an NMDA receptor antagonist, and blocking of NMDA receptors may increaseglutamate release. Taken together, low central NAAG levels may antagonize the effect of glutamate atNMDA receptors and decrease its agonistic effect on presynaptic mGluR3; both activities could increaseglutamate release, similar to the increase demonstrated in the PCP model of schizophrenia. In this report,it is suggested that the central NAAG deficit, possibly through decreased synthesis or increased degradationof NAAG, may play a role in the pathogenesis of schizophrenia. Evidence is presented and discussed frommagnetic resonance, postmortem, animal model, schizophrenia treatment, and genetic studies. The centralNAAG deficit model of schizophrenia could explain the disease process, from the perspectives of bothneurodevelopment and neurodegeneration, and may point to potential treatments for schizophrenia.
Keywords: Dipeptides - metabolism, Brain - metabolism, Aspartic Acid - metabolism, Glutamic Acid - metabolism, Models, Neurological, Receptors, N-Methyl-D-Aspartate - metabolism, Schizophrenia - metabolism
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
08 Mar 2024 : Laboratory Research
Evaluation of Retentive Strength of 50 Endodontically-Treated Single-Rooted Mandibular Second Premolars Res...Med Sci Monit In Press; DOI: 10.12659/MSM.944110
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952